Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Bo Ahren, Lund University
ClinicalTrials.gov Identifier:
NCT01779622
First received: January 27, 2013
Last updated: September 29, 2014
Last verified: September 2014

January 27, 2013
September 29, 2014
June 2013
January 2014   (final data collection date for primary outcome measure)
Area under the curve for insulin [ Time Frame: 300 min ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01779622 on ClinicalTrials.gov Archive Site
  • Area under the curve for glucose-dependent insuinotropic polypeptide [ Time Frame: 300 min ] [ Designated as safety issue: No ]
  • Area under the curve for glucagon-like peptide-1 [ Time Frame: 300 min ] [ Designated as safety issue: No ]
Same as current
Area under the curve for glucagon [ Time Frame: 300 min ] [ Designated as safety issue: No ]
Same as current
 
Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin Hormone Secretion in Healthy Volunteers
Rapid Versus Slow Ingestion of Mixed Meal: Influence on Islet and Incretin

To test the influence of rapid versus slow ingestion of a mixed meal on insulin and incretin hormone secretion in healthy volunteers

A mixed meal (524 kcal) is ingested rapidly (within 5 min) or slowly (10-15 min) and changes in insulin, glucagon, GIP and GLP-1 levels are followed for subsequent 300 min

Interventional
Not Provided
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science
Healthy Volunteers Recruited From the General Population
Other: Mixed meal
Ingestion of mixed meal
Experimental: 1
Healthy volunteers are ingesting a mixed meal either rapidly or slowly
Intervention: Other: Mixed meal
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
June 2014
January 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Healthy subjects

Exclusion Criteria:

  • Diabetes Liver disease Kidney disease Thyroid disease
Both
18 Years to 65 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Sweden
 
NCT01779622
17, 2013-000449-38
Yes
Bo Ahren, Lund University
Lund University
Not Provided
Not Provided
Lund University
September 2014

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP